Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kali Zhou

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Alimentary Pharmacology & Therapeutics|February 5, 2025
Editorial: Flipping the Script-Higher Risk of Hepatocellular Carcinoma With Tenofovir Compared to Entecavir in a French Population-Based CohortAriel Lee, Kali Zhou
Clinics in Liver Disease|October 5, 2020
Downstaging to Liver Transplant: Success Involves Choosing the Right PatientKali Zhou, Neil Mehta
AME Medical Journal|May 7, 2019
Immune tolerant HBV and HCC: time to revise our tolerance levels for therapy?Kali Zhou, Norah Terrault
Best Practice & Research. Clinical Gastroenterology|August 5, 2017
Management of hepatitis B in special populationsKali Zhou, Norah Terrault
Current Opinion in Organ Transplantation|October 7, 2020
Risk of disease transmission in an expanded donor population: the potential of hepatitis B virus donorsKali Zhou, Selena Zhou
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 17, 2024
Reply: Adopting a "cancer model" of referral to achieve equity in access to liver transplantationMelanie Hundt, Kali Zhou
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 8, 2019
Gaps in Viral Hepatitis Awareness in the United States in a Population-based StudyKali Zhou, Norah A Terrault
Alimentary Pharmacology & Therapeutics|May 31, 2025
Editorial: Chronic Hepatitis B at the Intersection of Immigration, Acculturation, and Social Determinants of Health-Authors' ReplyKali Zhou, Christine C Hsu
Alimentary Pharmacology & Therapeutics|April 26, 2022
Editorial: risk of hepatocellular carcinoma with tenofovir vs entecavir-a "knock-out" is yet to be deliveredAlexander V Tonthat, Kali Zhou
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 19, 2025
From screening to action: Social determinants and early outcomes in pediatric liver transplant recipientsTiange P Zhang, Kali Zhou
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Alimentary Pharmacology & Therapeutics|February 5, 2025
Editorial: Flipping the Script-Higher Risk of Hepatocellular Carcinoma With Tenofovir Compared to Entecavir in a French Population-Based CohortAriel Lee, Kali Zhou
Clinics in Liver Disease|October 5, 2020
Downstaging to Liver Transplant: Success Involves Choosing the Right PatientKali Zhou, Neil Mehta
AME Medical Journal|May 7, 2019
Immune tolerant HBV and HCC: time to revise our tolerance levels for therapy?Kali Zhou, Norah Terrault
Best Practice & Research. Clinical Gastroenterology|August 5, 2017
Management of hepatitis B in special populationsKali Zhou, Norah Terrault
Current Opinion in Organ Transplantation|October 7, 2020
Risk of disease transmission in an expanded donor population: the potential of hepatitis B virus donorsKali Zhou, Selena Zhou
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 17, 2024
Reply: Adopting a "cancer model" of referral to achieve equity in access to liver transplantationMelanie Hundt, Kali Zhou
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 8, 2019
Gaps in Viral Hepatitis Awareness in the United States in a Population-based StudyKali Zhou, Norah A Terrault
Alimentary Pharmacology & Therapeutics|May 31, 2025
Editorial: Chronic Hepatitis B at the Intersection of Immigration, Acculturation, and Social Determinants of Health-Authors' ReplyKali Zhou, Christine C Hsu
Alimentary Pharmacology & Therapeutics|April 26, 2022
Editorial: risk of hepatocellular carcinoma with tenofovir vs entecavir-a "knock-out" is yet to be deliveredAlexander V Tonthat, Kali Zhou
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 19, 2025
From screening to action: Social determinants and early outcomes in pediatric liver transplant recipientsTiange P Zhang, Kali Zhou
Pageof 7